LONDON, Sept 5 (Reuters) - The World Health Organization has added GLP-1 drugs to treat diabetes to its essential medicines list, alongside treatments for cystic fibrosis and cancer, and said it hopes ...
The World Health Organization (WHO) has, for the first time, added GLP-1 receptor agonists, popularly known as the active ingredients behind weight loss drugs like Ozempic and Wegovy to its Essential ...